Devices & Diagnostics

Medtronic to sell heart surgery tools made by Florida firm

Medtronic¬†(NYSE:MDT) announced Friday that it will begin to sell minimally invasive cardiac surgery instruments as part of a distribution agreement with a design company based in Florida. Miami Instruments designs surgical instruments for minimally invasive cardiac procedures, and Medtronic said that it is launching two of Miami Instruments’ products in the U.S. Terms of the […]

Medtronic (NYSE:MDT) announced Friday that it will begin to sell minimally invasive cardiac surgery instruments as part of a distribution agreement with a design company based in Florida.

Miami Instruments designs surgical instruments for minimally invasive cardiac procedures, and Medtronic said that it is launching two of Miami Instruments’ products in the U.S. Terms of the distribution agreement were not disclosed.

The two products are: the Joseph Lamelas Knot Pusher, which aims to “simplify the delivery and tying of suture knots in the heart during minimally invasive cardiac procedures” and the Joseph Lamelas Atrial Lift System, which can be used to “retract the atrial wall during limited-access cardiac surgical procedures,” according to Medtronic.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

“Medtronic is pleased to join with Miami Instruments to bring cardiac surgeons the specialized surgical instruments they need to perform MICS procedures on behalf of their patients,” said John Liddicoat, senior vice president, Medtronic and president of the Structural Heart business, in a news release. “This agreement will allow us to continue providing physicians with the most innovative minimally invasive heart valve replacement and repair technologies.”

The products are named after Dr. Joseph Lamelas, founder of Miami Instruments and cardiac surgeon, and chief of cardiac surgery at Mount Sinai Medical Center in Miami Beach, Florida. They will be used in heart valve repair

Miami Instruments’ products will be part of Medtronic’s Structural Heart business that saw revenue increase 8 percent to $266 million in the quarter ended Oct. 28.